img

Global Gemtuzumab Ozogamicin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gemtuzumab Ozogamicin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
Gemtuzumab Ozogamicin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gemtuzumab Ozogamicin market is projected to reach US$ 179.5 million in 2029, increasing from US$ 214.3 million in 2022, with the CAGR of -2.5% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gemtuzumab Ozogamicin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Segment by Type
5mg/Vial
4.5mg/Vial

Segment by Application


Hospital
Pharmacy

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gemtuzumab Ozogamicin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gemtuzumab Ozogamicin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gemtuzumab Ozogamicin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gemtuzumab Ozogamicin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gemtuzumab Ozogamicin introduction, etc. Gemtuzumab Ozogamicin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gemtuzumab Ozogamicin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Gemtuzumab Ozogamicin Market Overview
1.1 Gemtuzumab Ozogamicin Product Overview
1.2 Gemtuzumab Ozogamicin Market Segment by Type
1.2.1 5mg/Vial
1.2.2 4.5mg/Vial
1.3 Global Gemtuzumab Ozogamicin Market Size by Type
1.3.1 Global Gemtuzumab Ozogamicin Market Size Overview by Type (2018-2029)
1.3.2 Global Gemtuzumab Ozogamicin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gemtuzumab Ozogamicin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gemtuzumab Ozogamicin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gemtuzumab Ozogamicin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gemtuzumab Ozogamicin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gemtuzumab Ozogamicin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gemtuzumab Ozogamicin Sales Breakdown by Type (2018-2024)
2 Global Gemtuzumab Ozogamicin Market Competition by Company
2.1 Global Top Players by Gemtuzumab Ozogamicin Sales (2018-2024)
2.2 Global Top Players by Gemtuzumab Ozogamicin Revenue (2018-2024)
2.3 Global Top Players by Gemtuzumab Ozogamicin Price (2018-2024)
2.4 Global Top Manufacturers Gemtuzumab Ozogamicin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gemtuzumab Ozogamicin Market Competitive Situation and Trends
2.5.1 Gemtuzumab Ozogamicin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gemtuzumab Ozogamicin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gemtuzumab Ozogamicin as of 2022)
2.7 Date of Key Manufacturers Enter into Gemtuzumab Ozogamicin Market
2.8 Key Manufacturers Gemtuzumab Ozogamicin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gemtuzumab Ozogamicin Status and Outlook by Region
3.1 Global Gemtuzumab Ozogamicin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gemtuzumab Ozogamicin Historic Market Size by Region
3.2.1 Global Gemtuzumab Ozogamicin Sales in Volume by Region (2018-2024)
3.2.2 Global Gemtuzumab Ozogamicin Sales in Value by Region (2018-2024)
3.2.3 Global Gemtuzumab Ozogamicin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gemtuzumab Ozogamicin Forecasted Market Size by Region
3.3.1 Global Gemtuzumab Ozogamicin Sales in Volume by Region (2024-2029)
3.3.2 Global Gemtuzumab Ozogamicin Sales in Value by Region (2024-2029)
3.3.3 Global Gemtuzumab Ozogamicin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gemtuzumab Ozogamicin by Application
4.1 Gemtuzumab Ozogamicin Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Gemtuzumab Ozogamicin Market Size by Application
4.2.1 Global Gemtuzumab Ozogamicin Market Size Overview by Application (2018-2029)
4.2.2 Global Gemtuzumab Ozogamicin Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gemtuzumab Ozogamicin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gemtuzumab Ozogamicin Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gemtuzumab Ozogamicin Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gemtuzumab Ozogamicin Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gemtuzumab Ozogamicin Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gemtuzumab Ozogamicin Sales Breakdown by Application (2018-2024)
5 North America Gemtuzumab Ozogamicin by Country
5.1 North America Gemtuzumab Ozogamicin Historic Market Size by Country
5.1.1 North America Gemtuzumab Ozogamicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gemtuzumab Ozogamicin Sales in Volume by Country (2018-2024)
5.1.3 North America Gemtuzumab Ozogamicin Sales in Value by Country (2018-2024)
5.2 North America Gemtuzumab Ozogamicin Forecasted Market Size by Country
5.2.1 North America Gemtuzumab Ozogamicin Sales in Volume by Country (2024-2029)
5.2.2 North America Gemtuzumab Ozogamicin Sales in Value by Country (2024-2029)
6 Europe Gemtuzumab Ozogamicin by Country
6.1 Europe Gemtuzumab Ozogamicin Historic Market Size by Country
6.1.1 Europe Gemtuzumab Ozogamicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gemtuzumab Ozogamicin Sales in Volume by Country (2018-2024)
6.1.3 Europe Gemtuzumab Ozogamicin Sales in Value by Country (2018-2024)
6.2 Europe Gemtuzumab Ozogamicin Forecasted Market Size by Country
6.2.1 Europe Gemtuzumab Ozogamicin Sales in Volume by Country (2024-2029)
6.2.2 Europe Gemtuzumab Ozogamicin Sales in Value by Country (2024-2029)
7 Asia-Pacific Gemtuzumab Ozogamicin by Region
7.1 Asia-Pacific Gemtuzumab Ozogamicin Historic Market Size by Region
7.1.1 Asia-Pacific Gemtuzumab Ozogamicin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gemtuzumab Ozogamicin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gemtuzumab Ozogamicin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gemtuzumab Ozogamicin Forecasted Market Size by Region
7.2.1 Asia-Pacific Gemtuzumab Ozogamicin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gemtuzumab Ozogamicin Sales in Value by Region (2024-2029)
8 Latin America Gemtuzumab Ozogamicin by Country
8.1 Latin America Gemtuzumab Ozogamicin Historic Market Size by Country
8.1.1 Latin America Gemtuzumab Ozogamicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gemtuzumab Ozogamicin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gemtuzumab Ozogamicin Sales in Value by Country (2018-2024)
8.2 Latin America Gemtuzumab Ozogamicin Forecasted Market Size by Country
8.2.1 Latin America Gemtuzumab Ozogamicin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gemtuzumab Ozogamicin Sales in Value by Country (2024-2029)
9 Middle East and Africa Gemtuzumab Ozogamicin by Country
9.1 Middle East and Africa Gemtuzumab Ozogamicin Historic Market Size by Country
9.1.1 Middle East and Africa Gemtuzumab Ozogamicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gemtuzumab Ozogamicin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gemtuzumab Ozogamicin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gemtuzumab Ozogamicin Forecasted Market Size by Country
9.2.1 Middle East and Africa Gemtuzumab Ozogamicin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gemtuzumab Ozogamicin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gemtuzumab Ozogamicin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Gemtuzumab Ozogamicin Products Offered
10.1.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gemtuzumab Ozogamicin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gemtuzumab Ozogamicin Industrial Chain Analysis
11.4 Gemtuzumab Ozogamicin Market Dynamics
11.4.1 Gemtuzumab Ozogamicin Industry Trends
11.4.2 Gemtuzumab Ozogamicin Market Drivers
11.4.3 Gemtuzumab Ozogamicin Market Challenges
11.4.4 Gemtuzumab Ozogamicin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gemtuzumab Ozogamicin Distributors
12.3 Gemtuzumab Ozogamicin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 5mg/Vial
Table 2. Major Company of 4.5mg/Vial
Table 3. Global Gemtuzumab Ozogamicin Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (Units)
Table 5. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US& Million)
Table 7. Global Gemtuzumab Ozogamicin Market Share in Value by Type (2018-2024)
Table 8. Global Gemtuzumab Ozogamicin Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Gemtuzumab Ozogamicin Sales by Type (2024-2029) & (Units)
Table 10. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Gemtuzumab Ozogamicin Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Gemtuzumab Ozogamicin Sales Market Share in Value by Type (2024-2029)
Table 13. Global Gemtuzumab Ozogamicin Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (Units)
Table 15. North America Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Gemtuzumab Ozogamicin Sales (Units) by Type (2018-2024)
Table 17. Europe Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Gemtuzumab Ozogamicin Sales (Units) by Type (2018-2024)
Table 19. Asia-Pacific Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Gemtuzumab Ozogamicin Sales (Units) by Type (2018-2024)
Table 21. Latin America Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Gemtuzumab Ozogamicin Sales (Units) by Type (2018-2024)
Table 23. Middle East and Africa Gemtuzumab Ozogamicin Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Gemtuzumab Ozogamicin Sales by Company (2018-2024) & (Units)
Table 25. Global Gemtuzumab Ozogamicin Sales Share by Company (2018-2024)
Table 26. Global Gemtuzumab Ozogamicin Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Gemtuzumab Ozogamicin Revenue Share by Company (2018-2024)
Table 28. Global Market Gemtuzumab Ozogamicin Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Gemtuzumab Ozogamicin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Gemtuzumab Ozogamicin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gemtuzumab Ozogamicin as of 2022)
Table 32. Date of Key Manufacturers Enter into Gemtuzumab Ozogamicin Market
Table 33. Key Manufacturers Gemtuzumab Ozogamicin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Gemtuzumab Ozogamicin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Gemtuzumab Ozogamicin Sales by Region (2018-2024) & (Units)
Table 37. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Gemtuzumab Ozogamicin Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Gemtuzumab Ozogamicin Sales Market Share in Value by Region (2018-2024)
Table 40. Global Gemtuzumab Ozogamicin Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Gemtuzumab Ozogamicin Sales by Region (2024-2029) & (Units)
Table 42. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Gemtuzumab Ozogamicin Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Gemtuzumab Ozogamicin Sales Market Share in Value by Region (2024-2029)
Table 45. Global Gemtuzumab Ozogamicin Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Gemtuzumab Ozogamicin Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (Units)
Table 48. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Gemtuzumab Ozogamicin Sales Market Share in Value by Application (2018-2024)
Table 51. Global Gemtuzumab Ozogamicin Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Gemtuzumab Ozogamicin Sales by Application (2024-2029) & (Units)
Table 53. Global Gemtuzumab Ozogamicin Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Gemtuzumab Ozogamicin Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Gemtuzumab Ozogamicin Sales Market Share in Value by Application (2024-2029)
Table 56. Global Gemtuzumab Ozogamicin Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Gemtuzumab Ozogamicin Sales by Application (2018-2024) (Units)
Table 58. North America Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Gemtuzumab Ozogamicin Sales by Application (2018-2024) (Units)
Table 60. Europe Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Gemtuzumab Ozogamicin Sales by Application (2018-2024) (Units)
Table 62. Asia-Pacific Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Gemtuzumab Ozogamicin Sales by Application (2018-2024) (Units)
Table 64. Latin America Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Gemtuzumab Ozogamicin Sales by Application (2018-2024) (Units)
Table 66. Middle East and Africa Gemtuzumab Ozogamicin Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (Units)
Table 68. North America Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2018-2024)
Table 71. North America Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (Units)
Table 72. North America Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (Units)
Table 76. Europe Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (Units)
Table 80. Europe Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Gemtuzumab Ozogamicin Sales by Region (2018-2024) & (Units)
Table 84. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Gemtuzumab Ozogamicin Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Gemtuzumab Ozogamicin Sales by Region (2024-2029) & (Units)
Table 88. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Gemtuzumab Ozogamicin Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (Units)
Table 92. Latin America Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (Units)
Table 96. Latin America Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (Units)
Table 100. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Gemtuzumab Ozogamicin Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (Units)
Table 104. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Gemtuzumab Ozogamicin Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Gemtuzumab Ozogamicin Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Gemtuzumab Ozogamicin Product
Table 111. Pfizer Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Gemtuzumab Ozogamicin Market Trends
Table 115. Gemtuzumab Ozogamicin Market Drivers
Table 116. Gemtuzumab Ozogamicin Market Challenges
Table 117. Gemtuzumab Ozogamicin Market Restraints
Table 118. Gemtuzumab Ozogamicin Distributors List
Table 119. Gemtuzumab Ozogamicin Downstream Customers
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Gemtuzumab Ozogamicin Product Picture
Figure 2. Global Gemtuzumab Ozogamicin Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gemtuzumab Ozogamicin Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Gemtuzumab Ozogamicin Sales Status and Outlook (2018-2029) & (Units)
Figure 5. Product Picture of 5mg/Vial
Figure 6. Global 5mg/Vial Sales YoY Growth (2018-2029) & (Units)
Figure 7. Product Picture of 4.5mg/Vial
Figure 8. Global 4.5mg/Vial Sales YoY Growth (2018-2029) & (Units)
Figure 9. Global Gemtuzumab Ozogamicin Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Gemtuzumab Ozogamicin Sales Market Share by Type in 2022 & 2029
Figure 11. North America Gemtuzumab Ozogamicin Sales Market Share in Volume by Type in 2022
Figure 12. North America Gemtuzumab Ozogamicin Sales Market Share in Value by Type in 2022
Figure 13. Europe Gemtuzumab Ozogamicin Sales Market Share in Volume by Type in 2022
Figure 14. Europe Gemtuzumab Ozogamicin Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Value by Type in 2022
Figure 17. Latin America Gemtuzumab Ozogamicin Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Gemtuzumab Ozogamicin Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Gemtuzumab Ozogamicin Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Gemtuzumab Ozogamicin Revenue in 2022
Figure 23. Gemtuzumab Ozogamicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (Units)
Figure 26. Product Picture of Pharmacy
Figure 27. Global Pharmacy Sales YoY Growth (2018-2029) & (Units)
Figure 28. Global Gemtuzumab Ozogamicin Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Gemtuzumab Ozogamicin Sales Market Share by Application in 2022 & 2029
Figure 30. North America Gemtuzumab Ozogamicin Sales Market Share in Volume by Application in 2022
Figure 31. North America Gemtuzumab Ozogamicin Sales Market Share in Value by Application in 2022
Figure 32. Europe Gemtuzumab Ozogamicin Sales Market Share in Volume by Application in 2022
Figure 33. Europe Gemtuzumab Ozogamicin Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Gemtuzumab Ozogamicin Sales Market Share in Value by Application in 2022
Figure 36. Latin America Gemtuzumab Ozogamicin Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Gemtuzumab Ozogamicin Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Gemtuzumab Ozogamicin Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Gemtuzumab Ozogamicin Manufacturing Cost Structure
Figure 41. Gemtuzumab Ozogamicin Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed